5PSQ-060 Long-term effectiveness of omalizumab for chronic idiopathic urticaria in clinical practice | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Section 5: Patient safety and quality assurance

5PSQ-060 Long-term effectiveness of omalizumab for chronic idiopathic urticaria in clinical practice

Free

Online download statistics by month:

Online download statistics by month: March 2022 to August 2024

	Abstract	Full	Pdf
Mar 2022	19	0	2
Apr 2022	39	0	4
May 2022	14	0	3
Jun 2022	12	0	0
Jul 2022	20	0	2
Aug 2022	13	0	3
Sep 2022	16	0	3
Oct 2022	16	0	0
Nov 2022	32	0	6
Dec 2022	14	0	3
Jan 2023	14	0	0
Feb 2023	7	0	4
Mar 2023	10	0	0
Apr 2023	15	0	0
May 2023	4	0	1
Jun 2023	6	0	1
Jul 2023	14	0	3
Aug 2023	6	0	2
Sep 2023	14	0	1
Oct 2023	10	0	1
Nov 2023	17	0	1
Dec 2023	27	0	1
Jan 2024	2	0	1
Feb 2024	13	0	3
Mar 2024	6	0	4
Apr 2024	9	0	2
May 2024	16	0	1
Jun 2024	9	0	1
Jul 2024	4	0	3
Aug 2024	6	0	2
Total	404	0	58